Clover Health Investments, Corp. (CLOV) SEC filings

CLOVNasdaqHospital & Medical Service PlansFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30

$4.88−0.09 (-1.81%)

Close on Nov 12, 2026Market cap $2.59BP/E 488.0Yield –

SEC filings

40 of Clover Health Investments's most recent filings on SEC EDGAR

Document	Form	Period	Filed	Source
Quarterly report	10-Q	Sep 30, 2026	Nov 6, 2026	SEC EDGAR
Current report	8-K	Nov 2, 2026	Nov 4, 2026	SEC EDGAR
Current report	8-K	Oct 8, 2026	Oct 9, 2026	SEC EDGAR
Current report	8-K	Sep 22, 2026	Sep 24, 2026	SEC EDGAR
Current report	8-K	Aug 20, 2026	Aug 20, 2026	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2026	Aug 7, 2026	SEC EDGAR
Current report	8-K	Aug 5, 2026	Aug 5, 2026	SEC EDGAR
Current report	8-K	Jul 4, 2026	Jul 17, 2026	SEC EDGAR
Current report	8-K	Jun 17, 2026	Jun 18, 2026	SEC EDGAR
Current report	8-K	Jun 15, 2026	Jun 16, 2026	SEC EDGAR
Current report	8-K	Jun 10, 2026	Jun 12, 2026	SEC EDGAR
Current report	8-K	Jun 9, 2026	Jun 10, 2026	SEC EDGAR
Current report	8-K	May 18, 2026	May 18, 2026	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2026	May 8, 2026	SEC EDGAR
Current report	8-K	May 6, 2026	May 6, 2026	SEC EDGAR
Proxy statement	DEF 14A	Apr 28, 2026	Apr 28, 2026	SEC EDGAR
Current report	8-K	Mar 30, 2026	Apr 1, 2026	SEC EDGAR
Current report	8-K	Mar 6, 2026	Mar 6, 2026	SEC EDGAR
Annual report	10-K	Dec 31, 2025	Feb 27, 2026	SEC EDGAR
Current report	8-K	Feb 26, 2026	Feb 26, 2026	SEC EDGAR
Current report	8-K	Jan 14, 2026	Jan 14, 2026	SEC EDGAR
Current report	8-K	Dec 10, 2025	Dec 10, 2025	SEC EDGAR
Current report	8-K	Nov 12, 2025	Nov 12, 2025	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2025	Nov 7, 2025	SEC EDGAR
Current report	8-K	Nov 4, 2025	Nov 4, 2025	SEC EDGAR
Current report	8-K	Oct 31, 2025	Oct 31, 2025	SEC EDGAR
Current report	8-K	Oct 9, 2025	Oct 9, 2025	SEC EDGAR
Current report	8-K	Aug 11, 2025	Aug 11, 2025	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2025	Aug 8, 2025	SEC EDGAR
Current report	8-K	Aug 5, 2025	Aug 5, 2025	SEC EDGAR
Current report	8-K	Jun 10, 2025	Jun 12, 2025	SEC EDGAR
Current report	8-K	May 14, 2025	May 14, 2025	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2025	May 9, 2025	SEC EDGAR
Current report	8-K	May 6, 2025	May 6, 2025	SEC EDGAR
Proxy statement	DEF 14A	Apr 28, 2025	Apr 28, 2025	SEC EDGAR
Current report	8-K	Apr 21, 2025	Apr 22, 2025	SEC EDGAR
Annual report	10-K	Dec 31, 2024	Mar 3, 2025	SEC EDGAR
Current report	8-K	Feb 27, 2025	Feb 27, 2025	SEC EDGAR
Current report	8-K	Jan 13, 2025	Jan 13, 2025	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2024	Nov 8, 2024	SEC EDGAR

Where these numbers come from

Parsed from the XBRL in Clover Health Investments's annual and quarterly filings with the SEC
Per-share figures adjusted for the 19-for-3 split on May 17, 2021
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CLOV.

Compare: CLOV vs ALHC · CLOV vs OSCR · CLOV vs TRUP · CLOV vs MOH · CLOV vs CNO

Revenue growth54.5% · median 11.4%

Operating margin0.5% · median 1.8%

Net margin0.5% · median 2.7%

Company	Revenue	Growth
MOH	$44.13B	-0.9%
OSCR	$17.47B	+54.8%
ALHC	$4.94B	+35.9%
CNO	$4.54B	+2.3%
CLOV	$2.74B	+54.5%
TRUP	$1.56B	+11.4%

Company

Next earnings (est.): Feb 25, 2027, after close
Exchange: Nasdaq
Industry: Hospital & Medical Service Plans
Fiscal year ends: December 31
Employees: 724
Held by institutions: 27.5%
Auditor: Ernst & Young LLP
SEC CIK: 1801170

Advertisement
300 × 250

See a number that looks wrong?